 There was 143 sudden deaths in the clinical trial. She didn't see that as a safety signal. She pushed through the approval. Within a year, Roche had to withdraw the product because the cardiologists that were prescribing it, the primary care doctors that were prescribing it, the cardiologists, if they survived, but they were having heart attacks and suffering sudden deaths. Where have we seen that before? And they also would go into arrhythmias, and they would be pacemakers.